title: The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation.
authors.affiliation: Department of Family Medicine, UNC School of Medicine, Chapel Hill, NC 27599, USA. christine_kistler@med.unc.edu
authors.forename: Christine E
authors.initials: CE
authors.lastname: Kistler
authors.forename: Adam O
authors.initials: AO
authors.lastname: Goldstein
mesh_terms: D001552:Benzazepines / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged; D018722:Nicotinic Agonists / Q000009:adverse effects*; D011810:Quinoxalines / Q000009:adverse effects*; D018570:Risk Assessment; D012907:Smoking / Q000401:mortality*; D016540:Smoking Cessation / Q000379:methods*; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline